Hodgkin lymphoma is a cancer of the blood and bone marrow. Named for Dr. Thomas Hodgkin, the physician who first recognized the condition, Hodgkin lymphoma develops when white blood cells (lymphocytes) undergo abnormal changes that cause them to grow and divide at a very rapid pace, sometimes spreading beyond the lymphatic system. Because this type of cancer affects the body’s immune system, it can compromise the body’s ability to fight off infections.
There are two main types of lymphoma: Hodgkin and non-Hodgkin. A pathologist can usually differentiate between the two by examining a sample of the cancerous cells under a microscope or evaluating the results of other lab tests. Typing the lymphoma is an important part of the diagnostic process because the two types vary significantly in how they behave, grow, spread and respond to treatment. Non-Hodgkin lymphoma is the more common of the two forms.
At Moffitt Cancer Center, our Malignant Hematology Program is home to a multispecialty team of board-certified surgeons, medical oncologists, radiation oncologists, pathologists and other medical professionals who are dedicated to providing our patients with comprehensive, individualized treatment and supportive care. Our tumor board collaboratively develops a treatment plan for each patient, then monitors the patient’s progress on an ongoing basis, refining the plan as necessary.
The optimal approach for treating Hodgkin lymphoma can vary based on the stage of the cancer, the overall health of the patient and other unique factors. Some commonly recommended methods include:
- Radiation therapy
- Monoclonal antibodies (designed to target a specific antigen found on cancer cells)
- A combination of high-dose chemotherapy and stem cell transplantation
Moffitt offers the latest options in all forms of treatment for Hodgkin lymphoma. As a National Cancer Institute-designated Comprehensive Cancer Center, we perform extensive research that has received national recognition. With a unique bench-to-bedside philosophy, we are committed to making our research breakthroughs available for the benefit of our patients as quickly as possible. We also have a robust clinical trials program through which our patients have access to leading-edge treatments that are not yet widely available.
To schedule a visit with one of our expert oncologists, call 1-888-663-3488 or submit a new patient registration form online. Referrals are not required to receive Hodgkin lymphoma treatment at Moffitt.